You are here » Home » Companies » Company Overview » Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd.

BSE: 500124 Sector: Health care
NSE: DRREDDY ISIN Code: INE089A01023
BSE LIVE 15:55 | 05 Dec 3171.25 -8.50
(-0.27%)
OPEN

3179.75

HIGH

3191.60

LOW

3124.00

NSE LIVE 15:52 | 05 Dec 3168.15 -12.35
(-0.39%)
OPEN

3197.50

HIGH

3197.50

LOW

3118.55

OPEN 3179.75
PREVIOUS CLOSE 3179.75
VOLUME 15837
52-Week high 3689.00
52-Week low 2750.00
P/E 46.52
Mkt Cap.(Rs cr) 54158.61
Buy Price 3171.25
Buy Qty 5.00
Sell Price 0.00
Sell Qty 0.00
OPEN 3179.75
CLOSE 3179.75
VOLUME 15837
52-Week high 3689.00
52-Week low 2750.00
P/E 46.52
Mkt Cap.(Rs cr) 54158.61
Buy Price 3171.25
Buy Qty 5.00
Sell Price 0.00
Sell Qty 0.00

About Dr Reddys Laboratories Ltd.

Dr Reddys Laboratories Ltd

Dr Reddy's Laboratories Ltd is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. The company offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars, differentiated formulations and News Chemical Entities (NCEs) through their...> More

Dr Reddys Laboratories Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   54,159
EPS - TTM () [*C] 68.17
P/E Ratio (X) [*C] 46.52
Face Value ()   5
Latest Dividend (%)   400.00
Latest Dividend Date 18 Jul 2016
Dividend Yield (%) 0.63
Book Value / Share () [*C] 662.65
P/B Ratio () [*C] 4.79
[*C] Consolidated     [*S] Standalone

Dr Reddys Laboratories Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 3616.3 4020.7 -10.06
Other Income 43.8 72.4 -39.5
Total Income 3660.1 4093.1 -10.58
Total Expenses 2989.3 2888.2 3.5
Operating Profit 670.8 1204.9 -44.33
Net Profit 300.4 769 -60.94
Equity Capital 82.9 85.3 -
> More on Dr Reddys Laboratories Ltd Financials Results

Dr Reddys Laboratories Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Sun Pharma.Inds. 713.05 -0.89 171616.87
Lupin 1536.60 3.22 69354.44
Dr Reddy's Labs 3171.25 -0.27 54158.61
Cipla 573.20 0.32 46099.61
Aurobindo Pharma 724.95 0.77 42424.07
Cadila Health. 397.50 0.57 40692.08
> More on Dr Reddys Laboratories Ltd Peer Group

Dr Reddys Laboratories Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 26.68
Banks/FIs 0.17
FIIs 37.18
Insurance 3.55
Mutual Funds 2.75
Indian Public 8.14
Custodians 0.00
Other 21.54
> More on Dr Reddys Laboratories Ltd Share Holding Pattern

Dr Reddys Laboratories Ltd - Research Reports

Date Broker Action Price Report
26/07 Motilal Oswal Neutral 3323 PDF IconDetails
13/06 Motilal Oswal Neutral 3087 PDF IconDetails
12/05 Prabhudas Lilladher Accumulate 2971 PDF IconDetails
12/05 Motilal Oswal Neutral 2974 PDF IconDetails
29/10 Motilal Oswal Buy 4214 PDF IconDetails
> More on Dr Reddys Laboratories Ltd Research Reports

Dr Reddys Laboratories Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -0.14% -0.15% 0.00% 0.02%
1 Month 3.06% 2.87% -3.39% -3.62%
3 Month 1.56% 1.44% -7.65% -7.73%
6 Month 0.37% 0.25% -1.84% -1.12%
1 Year -0.74% -0.86% 2.77% 4.46%
3 Year 31.42% 31.20% 25.72% 30.25%

Dr Reddys Laboratories Ltd - STOCK STRENGTH

Today's Low/High 3124.00
3191.60
Week Low/High 3124.00
3247.00
Month Low/High 2960.40
3345.00
YEAR Low/High 2750.00
3689.00
All TIME Low/High 3.83
4383.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard